Browse

Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitors

Cited 10 time in Web of Science Cited 10 time in Scopus
Authors
Keam, Bhumsuk; Kang, Chang Kyung; Jun, Kang Il; Moon, Song Mi; Suh, Koung Jin; Lee, Dae-Won; Ock, Chan-Young; Kim, Miso; Choi, Yunhee; Lim, Yoojoo; Lee, Kyung-Hun; Kim, Se Hyun; Kim, Tae Min; Kim, Tae-Yong; Oh, Do-Youn; Kim, Dong-Wan; Im, Seock-Ah; Lee, Jong Seok; Kim, Eu Suk; Kim, Hong Bin; Kim, Nam-Joong; Kim, Yu Jung; Park, Wan Beom; Oh, Myoung-Don
Issue Date
2020-07
Citation
Clinical Infectious Diseases, Vol.71 No.2, pp.422-425
Keywords
influenzavaccinationimmune checkpoint inhibitorimmunogenicityimmune-related adverse event
Abstract
Among prospectively enrolled adult patients with cancer receiving immune checkpoint inhibitors (ICIs; n = 46) or cytotoxic agents (n = 90), seroprotection and seroconversion rates after seasonal quadrivalent influenza vaccinations were higher with ICI than with cytotoxic chemotherapy. These results support annual influenza vaccinations for cancer patients receiving ICIs.
ISSN
1058-4838
URI
https://hdl.handle.net/10371/171812
DOI
https://doi.org/10.1093/cid/ciz1092
Files in This Item:
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Internal Medicine (내과학전공)Journal Papers (저널논문_내과학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse